Dry eye syndrome has a common trigger that can be traced back to prevalent issues in modern life, particularly the widespread problems of mobile phone use and air pollution, both considered potential contributing factors. Its main characteristic is a lack of sufficient moisture on the surface of the eye, which can lead to discomfort and damage to the cornea. Through experimental verification, PROTAI™'s sequence-specific peptide has demonstrated outstanding effectiveness in increasing eye moisture. This peptide has been proven to possess the ability to promote corneal repair, showing improvements in both acute and chronic dry eye syndrome. In summary, the application of PROTAI™'s sequence-specific peptide holds the potential to alleviate symptoms of dry eye syndrome and may play a positive role in promoting eye health.
The aging of the skin is an inevitable physiological process that results in the loss of its natural elasticity and the appearance of wrinkles. PROTAI™ stands out for its outstanding characteristics, possessing several key functions, including strengthening antioxidant activity, promoting skin cell proliferation, superior wound repair and healing efficacy, while also providing excellent moisturizing effects. Furthermore, PROTAI™ has been proven to enhance skin elasticity, offering comprehensive care for the skin and effectively delaying skin aging.
Caring for patients with non-healing wounds is an extremely demanding responsibility. Experimental results indicate that PROTAI™ possesses remarkable repair capabilities, whether for incisions, burns, or wounds that are challenging to heal, especially in diabetic patients. For individuals with diabetes, the lowered immune function caused by diabetes makes wound healing even more challenging. Therefore, when diabetic patients observe an extended wound healing period, even for minor wounds, prompt and effective treatment is essential. Failure to initiate timely treatment may lead to infection, and in severe cases, it could progress to the point of requiring amputation of the affected limb. Hence, when diabetic patients experience such symptoms, it is crucial to promptly seek appropriate treatment to prevent further complications.
The patented cultivation technique for Antrodia Cinnamomea, using strains registered with NCBI, has successfully yielded individual strains of red and white Antrodia Cinnamomea. This achievement forms the basis of our patent. Utilizing a biopharmaceutical research and development platform, we extract beneficial components from plants using unique patented techniques. Through scientific validation, we ensure that our products achieve optimal functionality. Throughout the entire product development process, from research and development, raw material procurement, and technological application, to production, we have achieved seamless integration. To ensure the safety of the process and products, we adhere to the standards of HACCP and ISO22000, maintaining strict quality control throughout.
